[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:diabetic-foot-ulcer":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":313,"states":314},"Diabetic foot ulcer",71,59,[8,16,22,29,35,41,47,53,59,65,71,78,84,90,96,102,108,114,120,126,132,138,145,151,157,164,170,175,181,187,193,199,205,211,217,223,229,235,241,247,253,259,266,272,278,284,290,296,301,307],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06852976","A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers",[12],"Phase 2","RECRUITING","2026-08-26T02:16:07.529922Z","2026-05-05T02:43:29.730516Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06681428","Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers",[],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:29.670126Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07086443","Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy",[26],"Phase 4","2026-08-26T02:15:20.225313Z","2026-05-05T02:43:29.411064Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06600724","Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs",[],"2026-08-26T02:14:59.425132Z","2026-05-05T02:43:29.358501Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06515093","Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC",[],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:29.339222Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07161830","Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers",[],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:29.152055Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07209358","EDX110 Randomized Control Trial for Treatment of DFUs",[],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:29.054215Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07089602","Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers",[26],"2026-08-26T02:16:08.402952Z","2026-05-05T02:43:28.902716Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT06449638","Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs",[],"2026-08-26T02:15:48.613507Z","2026-05-05T02:43:28.880323Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT07116876","Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers",[],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:28.876567Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":76,"content_modified":77},"NCT05930210","A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer",[75],"Phase 3","2026-08-26T02:16:02.918558Z","2026-05-05T02:43:28.866750Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05758545","Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers",[],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:28.819394Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT07209475","Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.",[26],"2026-08-26T02:18:32.765187Z","2026-05-05T02:43:28.803870Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT07326553","Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing",[26],"2026-08-26T02:16:28.221034Z","2026-05-05T02:43:28.640575Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT07039396","Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers",[],"2026-08-26T02:17:59.904383Z","2026-05-05T02:43:28.565551Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT06826339","Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.",[26],"2026-08-26T02:18:49.989941Z","2026-05-05T02:43:28.513342Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT07046767","CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations",[],"2026-08-26T02:15:42.447052Z","2026-05-05T02:43:28.364336Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT04460573","Smart Boot Use to Measure Offloading Adherence",[12],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:28.127749Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT06616844","IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers",[],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:28.101631Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT06674980","Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs",[],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:27.986933Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT06939686","Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing",[],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:27.948850Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":143,"content_modified":144},"NCT07498218","Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue",[142],"Phase 1","2026-08-26T02:15:03.757872Z","2026-05-05T02:43:27.809137Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT06564831","Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care",[],"2026-08-26T02:19:29.922117Z","2026-05-05T02:43:27.600341Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":155,"content_modified":156},"NCT07223268","Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation",[],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:27.574355Z",{"nct_id":158,"title":159,"phases":160,"status":13,"updated_at":162,"content_modified":163},"NCT07396376","Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers",[161],"Phase 1\u002FPhase 2","2026-08-26T02:18:46.137046Z","2026-05-05T02:43:27.572985Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":168,"content_modified":169},"NCT04164641","Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration",[],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:27.429104Z",{"nct_id":171,"title":172,"phases":173,"status":13,"updated_at":63,"content_modified":174},"NCT07172893","A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL",[26],"2026-05-05T02:43:27.428230Z",{"nct_id":176,"title":177,"phases":178,"status":13,"updated_at":179,"content_modified":180},"NCT06278935","Adapting Lifestyle Offloading for DFUs",[],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:27.291501Z",{"nct_id":182,"title":183,"phases":184,"status":13,"updated_at":185,"content_modified":186},"NCT04791449","Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers",[],"2026-08-26T02:18:02.701182Z","2026-05-05T02:43:26.984362Z",{"nct_id":188,"title":189,"phases":190,"status":13,"updated_at":191,"content_modified":192},"NCT06550596","Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers",[],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:26.959779Z",{"nct_id":194,"title":195,"phases":196,"status":13,"updated_at":197,"content_modified":198},"NCT07159282","A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers",[26],"2026-08-26T02:17:35.666428Z","2026-05-05T02:43:26.919952Z",{"nct_id":200,"title":201,"phases":202,"status":13,"updated_at":203,"content_modified":204},"NCT06618612","A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers",[],"2026-08-26T02:19:09.651016Z","2026-05-05T02:43:26.770217Z",{"nct_id":206,"title":207,"phases":208,"status":13,"updated_at":209,"content_modified":210},"NCT07116174","A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs",[],"2026-08-26T02:16:42.787115Z","2026-05-05T02:43:26.745516Z",{"nct_id":212,"title":213,"phases":214,"status":13,"updated_at":215,"content_modified":216},"NCT06560502","Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs",[],"2026-08-26T02:18:59.761994Z","2026-05-05T02:43:26.743883Z",{"nct_id":218,"title":219,"phases":220,"status":13,"updated_at":221,"content_modified":222},"NCT06767501","Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care",[],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:26.689498Z",{"nct_id":224,"title":225,"phases":226,"status":13,"updated_at":227,"content_modified":228},"NCT07014176","Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)",[26],"2026-08-03T03:13:22.003666Z","2026-05-05T02:35:31.906540Z",{"nct_id":230,"title":231,"phases":232,"status":13,"updated_at":233,"content_modified":234},"NCT07364630","A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.",[26],"2026-08-26T02:16:40.941792Z","2026-05-05T02:35:31.614460Z",{"nct_id":236,"title":237,"phases":238,"status":13,"updated_at":239,"content_modified":240},"NCT06938685","Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers",[],"2026-08-26T02:16:59.895916Z","2026-04-29T02:57:57.061774Z",{"nct_id":242,"title":243,"phases":244,"status":13,"updated_at":245,"content_modified":246},"NCT04920253","Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center",[],"2026-08-26T02:16:09.452956Z","2026-05-05T02:43:28.901579Z",{"nct_id":248,"title":249,"phases":250,"status":13,"updated_at":251,"content_modified":252},"NCT04210089","Total Contact Soft Cast in Diabetic Foot Ulcers",[],"2026-08-26T02:18:42.501841Z","2026-05-05T02:43:28.880235Z",{"nct_id":254,"title":255,"phases":256,"status":13,"updated_at":257,"content_modified":258},"NCT06810726","Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.",[12],"2026-08-26T02:17:50.500039Z","2026-05-05T02:43:28.868494Z",{"nct_id":260,"title":261,"phases":262,"status":13,"updated_at":264,"content_modified":265},"NCT05169814","Micro\u002FNanobubbles (MNBs) for Treatment of Acute and Chronic Wounds",[263],"Early Phase 1","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:29.541481Z",{"nct_id":267,"title":268,"phases":269,"status":13,"updated_at":270,"content_modified":271},"NCT06939673","Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care",[],"2026-08-26T02:18:39.640967Z","2026-05-05T02:35:31.765204Z",{"nct_id":273,"title":274,"phases":275,"status":13,"updated_at":276,"content_modified":277},"NCT06487780","Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers",[],"2026-08-26T02:15:33.331531Z","2026-05-05T02:35:31.746968Z",{"nct_id":279,"title":280,"phases":281,"status":13,"updated_at":282,"content_modified":283},"NCT03942081","Diabetic Foot Ulcer Imaging- Study 2",[],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.742174Z",{"nct_id":285,"title":286,"phases":287,"status":13,"updated_at":288,"content_modified":289},"NCT07701590","CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs",[],"2026-08-26T02:15:30.699880Z","2026-07-19T19:36:05.084852Z",{"nct_id":291,"title":292,"phases":293,"status":13,"updated_at":294,"content_modified":295},"NCT07632001","Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers",[],"2026-08-26T02:15:04.877798Z","2026-06-14T18:39:22.250387Z",{"nct_id":297,"title":298,"phases":299,"status":13,"updated_at":33,"content_modified":300},"NCT07360418","Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.",[],"2026-05-13T02:55:06.696277Z",{"nct_id":302,"title":303,"phases":304,"status":13,"updated_at":305,"content_modified":306},"NCT06598241","Mirragen Diabetic Foot Ulcer Study",[],"2026-08-26T02:19:08.862440Z","2026-05-13T02:55:06.554538Z",{"nct_id":308,"title":309,"phases":310,"status":13,"updated_at":311,"content_modified":312},"NCT06104969","DFC 004 Biomarkers for Active Diabetic Foot Ulcers",[],"2026-08-26T02:16:11.347936Z","2026-05-13T02:55:06.415485Z",[],[315,319,323,327,331,335,338,342,345,349,353,357,360,364,367,370,373,377,380],{"state":316,"count":317,"slug":318},"Florida",25,"florida",{"state":320,"count":321,"slug":322},"California",23,"california",{"state":324,"count":325,"slug":326},"Texas",21,"texas",{"state":328,"count":329,"slug":330},"Pennsylvania",13,"pennsylvania",{"state":332,"count":333,"slug":334},"Arizona",10,"arizona",{"state":336,"count":333,"slug":337},"North Carolina","north-carolina",{"state":339,"count":340,"slug":341},"New York",9,"new-york",{"state":343,"count":340,"slug":344},"Ohio","ohio",{"state":346,"count":347,"slug":348},"Illinois",8,"illinois",{"state":350,"count":351,"slug":352},"Georgia",7,"georgia",{"state":354,"count":355,"slug":356},"Louisiana",5,"louisiana",{"state":358,"count":355,"slug":359},"Virginia","virginia",{"state":361,"count":362,"slug":363},"Maryland",4,"maryland",{"state":365,"count":362,"slug":366},"Massachusetts","massachusetts",{"state":368,"count":362,"slug":369},"Michigan","michigan",{"state":371,"count":362,"slug":372},"Oklahoma","oklahoma",{"state":374,"count":375,"slug":376},"Connecticut",3,"connecticut",{"state":378,"count":375,"slug":379},"Indiana","indiana",{"state":381,"count":375,"slug":382},"Missouri","missouri"]